Amgen is one of the world's biggest biotech drugmakers — bone, heart, and inflammation medicines.
Amgen Inc. (AMGN) is expected to report earnings on Tuesday, November 3, 2026, after the close. Estimated release time 16:03 ET. Consensus EPS estimate is $5.76.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | Jun 2026 qtr | $5.62 | $6.29 | +11.9% | $10.05B |
| 2026-04-30 | Mar 2026 qtr | $4.77 | $5.15 | +8.0% | $8.62B |
| 2026-02-03 | Dec 2025 qtr | $4.73 | $5.29 | +11.8% | $9.90B |
| 2025-11-05 | Sep 2025 qtr | $5.02 | $5.64 | +12.4% | $9.56B |
| 2025-08-06 | Jun 2025 qtr | $5.28 | $6.02 | +14.0% | $9.17B |
| 2025-05-02 | Mar 2025 qtr | $4.27 | $4.90 | +14.8% | $8.15B |
| 2025-02-04 | Dec 2024 qtr | $5.04 | $5.31 | +5.4% | $9.09B |
| 2024-10-31 | Sep 2024 qtr | $5.11 | $5.58 | +9.2% | $8.50B |
AMGN has beaten consensus EPS in 8 of its last 8 scored quarters.
AMGN pays a quarterly dividend, currently yielding 2.26%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-08-21 | $2.52 | 2026-09-11 |
| 2026-05-15 | $2.52 | 2026-06-05 |
| 2026-02-13 | $2.52 | 2026-03-06 |
| 2025-11-21 | $2.38 | 2025-12-12 |
| 2025-08-22 | $2.38 | 2025-09-12 |
| 2025-05-16 | $2.38 | 2025-06-06 |